New stent graft aims to fix aneurysms without major surgery

NCT ID NCT02692664

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a special stent graft (E-liac) to treat bulges in the iliac artery (aneurysms) without open surgery. 71 patients received the device, sometimes combined with other aortic grafts. The main goal was to prevent aneurysm rupture and death. Researchers tracked success by checking for complications like leaks, blockages, or aneurysm growth over 3 years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
E-liac Stent Graft (a device placed inside blood vessels to repair aneurysms)
What this could lead to
If successful, this stent graft could offer a less invasive way to treat iliac aneurysms, reducing the need for open surgery.
What could go wrong
This is a small, completed registry study (71 patients) without a comparison group. Results may not apply to all patients, and risks like graft blockage or aneurysm growth remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

71 people

The number who actually took part.

Started

May 2016

Finished

Jul 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male and female patients with unilateral or bilateral common iliac aneurysm, treated with the E-liac Stent Graft System

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Unilateral or bilateral aorto-iliac or iliac aneurysm * Suitable for endovascular repair * Patient must be compliant with life- long follow-up investigations * \>18 years old * lliac/femoral access vessel morphology compatible with the implantation procedure and the 18Fr (6mm OD) delivery system * Non-aneurysmal common iliac artery landing area in case of iliac artery aneurysm ≥ 20mm * Diameter of the common iliac artery in the proximal landing area: 12mm to 17mm * Non-aneurysmal external iliac artery segment distal to the aneurysm ≥15mm * Diameter of the external iliac artery in the distal landing area: 8mm to 13mm * Non-aneurysmal internal iliac artery segment distal to the aneurysm ≥15mm * Angle between external iliac artery and internal iliac artery ≤50° * Thrombus free iliac lumen in the area of iliac bifurcation to open hypogastric side branch and to implant covered stent ≥18mm * Sufficiently open internal iliac arterv ostium * Patients must comply with the instructions for use. * Patients with common iliac aneurysm with a diameter ≥30mm when isolated or common iliac aneurysm with a diameter \>25mm when associated with an abdominal aortic aneurysm * Unilateral or bilateral common iliac aneurysm * Patient's anatomy must be fit for stent graft placement on preoperative angio CT scan. * Patient is affiliated to the social security or equivalent system. * The patient must be available for the appropriate follow-up times for the duration of the study. * Patient has been informed of the nature of the study, agrees to its provisions and has signed the informed consent from. Exclusion Criteria: * Patients who do not meet the instructions for use * Patients with one of the contraindications as indicated in the instructions for use * Patients with a stenotic internal iliac ostium of \< 4mm in Diameter * Patients with severe internal iliac atherosclerosis * Patients that do not have a suitable landing area in the main stem of the IIA (maximum diameter in landing area \<12mm) * Patients with pseudoaneurysms * Patients with symptomatic and ruptured iliac aneurysms * Patients pretreated with a AAA stent graft or a bifurcated vascular graft * Patient with thrombocytopenia * Patient with an estimated glomerular filtration rate \< 30 ml/min/1,73m2 immediately before the Intervention * Female of child bearing potential * In the lnvestigator's opinion patient has (a) eo-morbid condition(s) that could limit the patient's ability to participate in the study, compliance with follow-up requirements, or impact the scientific integrity of the study * Patient is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints * Patient with malignancy needing chemotherapy or radiation * Patients with life expectancy of less than 36 months * Patient minor or under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AAA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Iliac Aneurysm triple-A syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Nantes

    Nantes, France

  • CHU Rennes

    Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.